<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

SmartTRAK Life Sciences News and Analysis Blog

5 min read

Q318 OrthoBio Market Recap: Acquisitions and Partnerships Rule

12/14/18, 2:28 PM

Q318 OrthoBio RecapAcquisitions and Partnerships are Highpoints in Q318

SmartTRAK reports that the US OrthoBio Market (comprised of Bone Replacement, Cartilage, Soft Tissue and Meniscus) is growing at 4.1% YTD. For Q318, there were no surprises and the segment reached...

Among the many topics covered in the Q318 OrthoBio Market Recap are:

  • Market Overview
  • Market Dynamics Continue to Shape the Bone Replacement Segment
  • US Stem Cells Segment
  • US Bone Growth Factors Segment
  • US Synthetics Segment
  • US DBM Segment
  • US Spinal Constructs
  • Strong Performance for US Cartilage Replacement Market
  • US Soft Tissue Replacement Segment Softens Slightly
  • Challenges Continue for Meniscal Allografts
  • Regulatory Approval Highlights Q318

Competition within in the market is propelling companies to be more strategic, leading to partnerships, acquisitions, divestitures and increased investments in product development and commercialization...

Read the entire Q318 US OrthoBio Market Recap including news, data and analysis*...

*This article can only be viewed by SmartTRAK subscribers to this module. For information on how to subscribe, please click the button below.

Request SmartTRAK Subscription Info

Topics: Orthopedics

Kim French
Written by Kim French

20+ years of progressive medical device and biologics marketing and sales experience in orthopedic biological implants, cellular technologies and biopharmaceuticals. Most recent experience includes President, Trilogy Consulting and Marketing and Sales Management roles at AlloSource and Terumo BCT.

    Recent Articles